ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.35
0.33%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,351.345
0.19%
Brent Oil
84.17
0.26%
Bitcoin
62,910.76
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aeterna Zentaris Inc (AEZS) Share Price

AEZS Aeterna Zentaris Inc

7.84
0.04 (0.51%)
10 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Aeterna Zentaris Inc NASDAQ:AEZS NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.04 0.51 7.84 7.82 7.98 8.1392 7.84 7.89 11,356 23:07:07   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 4.5M -16.55M -3.4087 -2.30 38.07M
 Type  Size  Price  Time  Units 
 9 40 7.82 23:07:07 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore AEZS News
01/05/202412:55GLOBEAeterna Zentaris Announces Effective Date of Share Consolidation
28/03/202411:55GLOBECeapro Receives Final Court Approval for Merger with Aeterna Zentaris
28/03/202411:55GLOBECeapro Receives Final Court Approval for Merger with Aeterna Zentaris
27/03/202412:05GLOBEAeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
12/03/202418:10GLOBEAeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
12/03/202418:10GLOBEAeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
26/02/202412:30GLOBELeading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
Period
Draw mode
Data Downloads for AEZS

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Aeterna Zentaris Inc Articles